Skip to content
10-Q

Quarterly Report

Shuttle Pharmaceuticals, Inc.

0001615774-17-006889

← back to feed
Filed
Nov 20, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Nov 20, 2017 45M sh
Operating Cash Flow Q3 2017 · Sep 30, 2017 −$55.51K
Operating Cash Flow Q3 2017 · Sep 30, 2016 −$210.41K
Cash And Equivalents Q3 2017 · Sep 30, 2017 $66.54K
Cash And Equivalents Q3 2017 · Dec 31, 2016 $92.8K
Cash And Equivalents Q3 2017 · Sep 30, 2016 $120.09K
Cash And Equivalents Q3 2017 · Dec 31, 2015 $128.84K
Stockholders Equity Q3 2017 · Sep 30, 2017 −$300.3K
Stockholders Equity Q3 2017 · Dec 31, 2016 −$70.85K
Current Liabilities Q3 2017 · Sep 30, 2017 $356.43K
Current Liabilities Q3 2017 · Dec 31, 2016 $105.28K
Total Liabilities Q3 2017 · Sep 30, 2017 $476.68K
Total Liabilities Q3 2017 · Dec 31, 2016 $225.53K
Current Assets Q3 2017 · Sep 30, 2017 $152.14K
Current Assets Q3 2017 · Dec 31, 2016 $115.93K
Total Assets Q3 2017 · Sep 30, 2017 $176.39K
Total Assets Q3 2017 · Dec 31, 2016 $154.68K
Sga Expense Q3 2017 · Sep 30, 2017 $28.66K
Sga Expense Q3 2017 · Sep 30, 2017 $130.97K
Sga Expense Q3 2017 · Sep 30, 2016 $52.28K
Sga Expense Q3 2017 · Sep 30, 2016 $126.48K
Rd Expense Q3 2017 · Sep 30, 2017 $137.08K
Rd Expense Q3 2017 · Sep 30, 2017 $733.58K
Rd Expense Q3 2017 · Sep 30, 2016 $150.58K
Rd Expense Q3 2017 · Sep 30, 2016 $409.07K
Net Income Q3 2017 · Sep 30, 2017 −$46.85K
Net Income Q3 2017 · Sep 30, 2017 −$229.54K
Net Income Q3 2017 · Sep 30, 2016 −$121.94K
Net Income Q3 2017 · Sep 30, 2016 −$248.85K
Operating Income Q3 2017 · Sep 30, 2017 −$43.87K
Operating Income Q3 2017 · Sep 30, 2017 −$221.57K
Operating Income Q3 2017 · Sep 30, 2016 −$120.89K
Operating Income Q3 2017 · Sep 30, 2016 −$248.18K
Capex Q3 2017 · Sep 30, 2016 $4.33K